About
Alexandra Rundberg Nilsson is a postdoctoral Research Fellow at Lund University Cancer Centre (LUCC) and StemTherapy, with a focus on molecular medicine and gene therapy at Lund University's Division of Molecular Medicine and Gene Therapy. Her work intersects cancer biology, hematopoietic stem cell regulation, aging, and inflammation, contributing to UN Sustainable Development Goals in health and well-being.
- Research Interests: Epigenetic mechanisms in pancreatic cancer progression, stress-responsive regulation of hematopoietic stem cells, aging-related hematopoietic impairments, and inflammatory mediator dynamics.
- Methodologies: Utilizes mouse models, organoid systems, flow cytometry, and transcriptional profiling to study KRAS-driven cancer, TNF-α signaling, and IRF1-mediated stem cell maintenance.
Article Trends: Recent publications highlight her work on epigenetic loops (NRF2-EZH2) in cancer, radiation-induced stem cell damage, reversible TNF-α effects, and mitochondrial drug targeting (metformin) for inflammatory diseases. Her 2025 studies on pancreatic cancer and radiation biology represent the forefront of her research.
Peer Review: Actively involved in editorial work for Stem Cell Reports (2024–2025) and EMBO Journal (2023), indicating expertise in stem cell and molecular biology domains.
